Literature DB >> 4313869

Some properties of angiotensin converting enzyme in the lung in vivo.

K K Ng, J R Vane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4313869     DOI: 10.1038/2251142b0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  History of the development of inhibitors of angiotensin I conversion.

Authors:  S H Ferreira
Journal:  Drugs       Date:  1985       Impact factor: 9.546

2.  Fate of angiotension I in the total Bufo melanostictus.

Authors:  K K Ng
Journal:  Br J Pharmacol       Date:  1973-07       Impact factor: 8.739

3.  Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.

Authors:  P Y Wong; R C Talamo; G H Williams; R W Colman
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

4.  Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production.

Authors:  Juliano R Guerreiro; Claudiana Lameu; Eduardo F Oliveira; Clécio F Klitzke; Robson L Melo; Edlaine Linares; Ohara Augusto; Jay W Fox; Ivo Lebrun; Solange M T Serrano; Antonio C M Camargo
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

Review 5.  The clinical potential of renin inhibitors and angiotensin antagonists.

Authors:  R J Cody
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 6.  Drug-induced visceral angioedema.

Authors:  Prashanth M Thalanayar; Ibrahim Ghobrial; Fritz Lubin; Reena Karnik; Robin Bhasin
Journal:  J Community Hosp Intern Med Perspect       Date:  2014-09-29

Review 7.  Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.

Authors:  Luz Lozano-Maneiro; Adriana Puente-García
Journal:  J Clin Med       Date:  2015-11-09       Impact factor: 4.241

8.  Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia.

Authors:  A Gadelha; A M Vendramini; C M Yonamine; M Nering; A Berberian; M A Suiama; V Oliveira; M T Lima-Landman; G Breen; R A Bressan; V Abílio; M A F Hayashi
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.